Mark Chalmers is a Partner in the EY Life Sciences Commercial Strategy and Market Access team, leveraging over 15 years of experience in global commercial and launch strategies for pharmaceutical and biotech companies. Mark has a comprehensive background in healthcare systems and health technology assessment, with expertise in oncology, immunology, and advanced therapies. Prior to joining EY in 2021, Mark held various roles, including Director at Navigant and Principal & EU Lead at CBPartners. Mark earned a BSc in Pharmacology from The University of Edinburgh and a PhD in Pharmacology & Molecular Biology from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices